| Variable | Stage of Cancer | Total (N = 185) | χ2 /F | p | ||
| 1 (n = 46) | 2 (n = 96) | 3 (n = 43) | ||||
| Age [m ± SD] | 58.36 ± 13.32 | 55.84 ± 13.09 | 53.95 ± 11.95 | 56.10 ± 12.94 | 1.50 | 0.23 |
| Size of cancer [m ± SD] | 1.46 ± 0.50 | 2.98 ±1.01 | 3.30 ± 1.58 | 2.68 ± 1.29 | 39.79 | ≤0.001 |
| Personal history of cancer [n (%)] |
|
|
|
| 0.44 | 0.80 |
| No | 45(97.8) | 93(96.9) | 41 (95.3) | 179 (96.8) |
|
|
| Yes | 1 (2.2) | 3 (3.1) | 2 (4.7) | 6 (3.2) |
|
|
| Family history of cancer [n (%)] |
|
|
|
| 0.33 | 0.85 |
| No | 10 (21.7) | 22 (22.9) | 8 (18.6) | 40 (21.6) |
|
|
| Yes | 36 (78.3) | 74 (77.1) | 35 (81.4) | 145 (78.4) |
|
|
| Grade of cancer [n (%)] |
|
|
|
| 1.51 | 0.47 |
| Grade 1 - 2 | 14 (30.4) | 21 (21.9) | 9 (20.9) | 44 (23.8) |
|
|
| Grade 3 | 32 (69.6) | 75 (78.1) | 34 (79.1) | 141 (76.2) |
|
|
| Hormonal therapy [n (%)] |
|
|
|
| 0.25 | 0.88 |
| No | 42 (91.3) | 87 (90.6) | 38 (88.4) | 167 (90.3) |
|
|
| Yes | 4 (8.7) | 9 (9.4) | 5 (11.6) | 18 (9.7) |
|
|
| Chemotherapy |
|
|
|
| 17.51 | ≤0.001 |
| No | 19 (41.3) | 20 (20.8) | 2 (4.7) | 41 (22.2) |
|
|
| Yes | 27 (58.7) | 76 (79.2) | 41 (95.3) | 144 (77.8) |
|
|
| Radiation therapy [n (%)] |
|
|
|
| 4.06 | 0.132 |
| Yes | 20 (43.5) | 33 (34.4) | 10 (23.3) | 63 (34.1) |
|
|
| No | 26 (56.5) | 63 (65.6) | 33 (76.7) | 122 (65.9) |
|
|